Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
Results 1 to 10 of total 482
Im Fachmagazin "Cell" erschienene Studie zeigt ausgeprägte Vernarbung der Lunge durch gestörte Immunreaktion
Study by CiiM and MHH investigates biomarkers that can enable prognosis on therapy success
Guests can participate online in the event on 29 November
World Antimicrobial Awareness Week from 18 to 24 November draws attention to the issue
HZI-researchers and collaboration partners establish force measurements on single molecules
Federal Agency for Disruptive Innovation funds four projects with HZI participation
Grant is dedicated to the pre-commercial development of LEOPARD, a new diagnostic technology
Immunologists at the University Medical Center Magdeburg and the HZI have deciphered a new role of nitric oxide in the defense against pathogens
New concept aims to develop broadly effective therapeutics against viruses
HZI researchers find bacterial opponent of a dreaded hospital germ
You can also find a selection of our press releases on the page of Informationsdienst Wissenschaft